Navigation Links
Esperance Pharmaceuticals Completes $7.5 Million Series B Financing
Date:6/1/2011

ion."

Esperance is using its CLYP™ technology to develop a robust portfolio of novel targeted membrane-disrupting peptides (tMDPs) to selectively destroy cancer cells that express target receptors. EP-100, the lead candidate, is designed to seek and destroy cancer cells that over-express luteinizing hormone releasing hormone (LHRH) receptors on their surfaces and is currently in a Phase 1 study in patients with advanced solid tumors. LHRH receptors are over-expressed in a wide range of human cancers including breast, prostate, endometrial, pancreatic, ovarian, skin, testicular and blood cancers. In addition to EP-100, Esperance has other drug candidates in preclinical stages of development, all of which have a unique targeting mechanism of action whereby candidates bind specifically and exclusively to surface antigens or receptors on cancer cells.

About Esperance Pharmaceuticals

Esperance Pharmaceuticals, Inc. is a clinical stage company developing a new class of targeted anticancer drugs using its Cationic Lytic Peptide (CLYP™) platform technology. These drug candidates, called targeted membrane-disrupting peptides (tMDPs) and antibody drug conjugates (ADCs) selectively seek and destroy cancer cells, including cells known to be resistant to chemotherapeutic drugs, without harming normal cells. Targeting occurs through binding to specific receptors and antigens on the cell's surface. The Company was founded on patented technology discovered by scientists at the Pennington Biomedical Research Center, the Louisiana State (LSU) Ag Center and LSU main campus. Founding investors include the Louisiana Fund I, Themelios Ventures and Research Corporation Technologies. Additional investors include Sanofi, Advantage Capital Partners/Louisiana Technology Fund and private investors. More information can be found at www.esperancepharma.com.


'/>"/>
SOURCE Esperance Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. First Candidate from Esperances Targeted Anti-cancer Platform, EP-100, Establishes Preclinical Proof of Concept
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
6. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
7. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
8. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
9. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
10. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
11. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... NEW YORK , Oct. 1, 2014 ... market and is marked by the ,Threat of Obsolescence, ... users changes very rapidly. Pharmaceutical and biotechnology companies as ... on using high content screening as a powerful research ... market is the fastest-growing segment in the high content ...
(Date:10/1/2014)... Ohio , Oct. 1, 2014 /PRNewswire/ ... shareholders is now available. Interested parties can learn ... how Cardinal Health is supporting the health ... http://cardinalhealth.com/annualreport . Photo- ... to summary financials and the chief executive ...
(Date:10/1/2014)... NOTTINGHAM, England , Oct. 1, 2014 /PRNewswire/ ... announced that its subsidiary, Molecular Profiles Ltd., is set ... the annual CPhI/ICSE Worldwide event in Paris ... with the rapid development of both standard and complex ... platform, which incorporates the company,s existing formulation and analytical ...
Breaking Medicine Technology:High Content Screening Market by Instruments (Cell Imaging and Analysis System), by Applications (Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling), Software & Services - Global Forecasts to 2High Content Screening Market by Instruments (Cell Imaging and Analysis System), by Applications (Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling), Software & Services - Global Forecasts to 3Cardinal Health 2014 Digital Report to Shareholders Now Available 2Columbia Laboratories' UK Subsidiary To Launch New Development Platform At CPHI 2Columbia Laboratories' UK Subsidiary To Launch New Development Platform At CPHI 3
... TEL AVIV, Israel, May 5, 2011 InspireMD, Inc. (OTC ... MGuard™ mesh protective stent system, announced today that it has ... the Over-the-Counter Bulletin Board (OTCBB) under the symbol "NSPR". ... $9.7 million PIPE offering in which (i) it raised approximately ...
... Today, the Consumer Healthcare Products Association (CHPA), ... pediatric acetaminophen medicines, announces plans to convert these ... transition is taking place, starting in mid-2011, parents ... products with confidence as current labeling and dosing ...
Cached Medicine Technology:InspireMD to Commence Trading as a Public Company Under Ticker Symbol "NSPR" 2InspireMD to Commence Trading as a Public Company Under Ticker Symbol "NSPR" 3InspireMD to Commence Trading as a Public Company Under Ticker Symbol "NSPR" 4InspireMD to Commence Trading as a Public Company Under Ticker Symbol "NSPR" 5OTC Industry Announces Voluntary Transition to One Concentration of Single-Ingredient Pediatric Liquid Acetaminophen Medicines 2
(Date:10/2/2014)... (PRWEB) October 02, 2014 BamboofloorChina.com is ... its products have won great appreciation from the global ... is working hard to make more excellent items. All ... ready to help all clients. , The company ... panels to its website. Furthermore, the company’s marketing ...
(Date:10/2/2014)... News) -- Scientists have pinpointed a molecule that may ... The researchers say this finding could offer a ... these attacks. Most asthma attacks (80 percent to ... airways, according to the British researchers. Most of these ... common cold. The researchers found that a specific ...
(Date:10/2/2014)... Reinberg HealthDay Reporter WEDNESDAY, ... major highway may raise your risk for high blood pressure, ... women, those who lived within 109 yards of a busy ... blood pressure than women living at least half a mile ... highlight the importance of our physical environment on our health ...
(Date:10/2/2014)... Dennis Thompson ... News) -- Hospitals that pull out all the stops ... at saving lives, but the cost of such heroism ... hospitals are about 5 percent better at saving elderly ... hospitals that operate with less intensity, said senior author ...
(Date:10/1/2014)... of Adelaide have developed a model that could help ... from treatment - from their very first psychotic episode. ... factors, including clinical symptoms, cognitive abilities, MRI scans of ... , Speaking in the lead up to World Mental ... Psychiatry , Professor Bernhard Baune , says the ...
Breaking Medicine News(10 mins):Health News:High Quality Bamboo Panels Online At BamboofloorChina.com 2Health News:New Clues to How Colds Can Spur Asthma Attacks 2Health News:Living Near a Highway May Be Bad for Your Blood Pressure 2Health News:Living Near a Highway May Be Bad for Your Blood Pressure 3Health News:'High-Intensity' Hospitals Save More Elderly After Surgery: Study 2Health News:'High-Intensity' Hospitals Save More Elderly After Surgery: Study 3Health News:Predicting the future course of psychotic illness 2
... ... service available around the globe and simple to use, with more than ... only registration, upload of funds and you are ready to call your ... to establish the phone call. SOS Talk is fully automated, serving not ...
... ... media issues as the space rapidly evolves. Smart companies are learning to engage their audiences ... (PRWEB) ... valuable marketing & research tools available. Big pharma companies looking for an information edge are ...
... ... They don,t need the pretty bottles or sweet aroma of fragrant lotions and ... is tailored specifically to a man,s needs without added synthetic ingredients that may ... Adam uses the purity of nature to enhance the skin,s surface and makes ...
... ... fear out of processing grief after an abortion. C.P.R. Choice Processing and Resolution ... might feel after their voluntary pregnancy termination or abortion . Women caught off ... www.sadafterabortion.com for reassurance and some free resources. , ...
... ... they have recently been awarded an agreement with Premier Partners L.P., the group purchasing unit ... and serves 2,300 hospitals and more than 66,000 other healthcare sites representing over $33 billion ... Jackson, ...
... Cosmetic ... new buy back plan. , ... (PRWEB) – CosmeticLaserWorld.com ( www.cosmeticlaserworld.com ), a market leader in cost-effective cosmetic ... equipment from the reseller. Under an Investment Protection Plan, the company will buy back ...
Cached Medicine News:Health News:SOS Talk a New Way of Telephone Interpreting Serving the Globe, No Reservation or Start-Up Cost, Just Pay as You Go 2Health News:Pharma Companies Head Toward The Social Media Dialogue 2Health News:Garden of Eve Launches a Father's Day Tribute for Men Who Want to Look Well-groomed with Little Fuss 2Health News:Garden of Eve Launches a Father's Day Tribute for Men Who Want to Look Well-groomed with Little Fuss 3Health News:Garden of Eve Launches a Father's Day Tribute for Men Who Want to Look Well-groomed with Little Fuss 4Health News:New Website and Self-Help Book Validate Women Experiencing Grief After an Abortion 2Health News:New Website and Self-Help Book Validate Women Experiencing Grief After an Abortion 3Health News:New Website and Self-Help Book Validate Women Experiencing Grief After an Abortion 4Health News:Midbrook Medical Announces Agreement with Premier Partners L.P. 2Health News:Midbrook Medical Announces Agreement with Premier Partners L.P. 3Health News:CosmeticLaserWorld.com Gives Buyers Peace of Mind Through Industry-Leading Investment Protection Plan 2
Fully automated immunochemiluminometric assay for the rapid intraoperative,measurement of Intact PTH 1-84 using human serum or EDTA plasma....
... The innovative PoleStar N20, exclusively distributed ... intra-operative MRI. Combining intra-operative imaging ... registration-free system, PoleStar N20 is one ... available today. , , Exceptional image ...
... nm and 940 nm) laser system is ... solid-state laser quickly and effectively treats vascular ... offers the clinical versatility to precisely target ... vessels in a convenient, affordable package. , ...
Microwell IRMA for the detection of Intact PTH...
Medicine Products: